Maryka Quik Selected Research

pozanicline

10/2014	Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.
4/2014	ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maryka Quik Research Topics

Disease

47	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2002
30	Dyskinesias (Dyskinesia) 01/2019 - 11/2004
11	Parkinsonian Disorders (Parkinsonism) 01/2017 - 11/2004
7	Movement Disorders (Movement Disorder) 01/2019 - 05/2007
5	Tardive Dyskinesia 01/2019 - 03/2012
4	Nervous System Diseases (Neurological Disorders) 10/2011 - 02/2006
3	Tobacco Use Disorder (Nicotine Dependence) 12/2013 - 02/2006
2	Ataxia (Dyssynergia) 01/2019 - 10/2014
2	Tourette Syndrome (Tourette's Syndrome) 01/2019 - 10/2014
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 02/2015 - 08/2012
2	Schizophrenia (Dementia Praecox) 10/2014 - 03/2012
2	Psychotic Disorders (Schizoaffective Disorder) 10/2014 - 03/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2006 - 10/2002
1	Drug-Induced Dyskinesia (Dyskinesia, Drug Induced) 01/2019
1	Dystonia (Limb Dystonia) 01/2019
1	Obesity 01/2016
1	Weight Gain 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 12/2015
1	Mental Disorders (Mental Disorder) 10/2014
1	Catalepsy 03/2012
1	Tremor (Tremors) 10/2009
1	Hypokinesia (Bradykinesia) 10/2009
1	Disease Progression 09/2008
1	Neuroblastoma 05/2008
1	Neuralgia (Stump Neuralgia) 03/2008
1	Vomiting 05/2007
1	Basal Ganglia Diseases (Basal Ganglia Disease) 04/2002

Drug/Important Bio-Agent (IBA)

37	Nicotine FDA Link 01/2019 - 10/2002
32	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019 - 01/2002
31	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 09/2003
14	Dopamine (Intropin)FDA LinkGeneric 01/2015 - 09/2003
11	Pharmaceutical PreparationsIBA 12/2016 - 03/2005
6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 09/2013 - 11/2004
5	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 03/2012
5	Cholinergic Agents (Cholinergics)IBA 01/2019 - 10/2014
4	Nicotinic AgonistsIBA 05/2011 - 10/2002
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015 - 12/2007
3	LigandsIBA 10/2009 - 10/2002
2	5- (6- (1- azabicyclo(2,2,2)oct- 3- yloxy)pyridazin- 3- yl)- 1H- indoleIBA 12/2015 - 10/2014
2	3- (5,6- dichloropyridin- 3- yl)- 3,6- diazabicyclo(3.2.0)heptaneIBA 12/2015 - 04/2014
2	pozaniclineIBA 10/2014 - 04/2014
2	Varenicline (Chantix)FDA Link 10/2014 - 08/2012
2	Neuroprotective AgentsIBA 10/2014 - 07/2012
2	Drinking WaterIBA 10/2008 - 12/2007
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	SugarsIBA 01/2016
1	Carbidopa (Lodosyn)FDA LinkGeneric 12/2015
1	ABT-126IBA 12/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	SmokeIBA 01/2015
1	Dihydroxyphenylalanine (Dopa)IBA 09/2013
1	TC-8831IBA 08/2013
1	Oxidopamine (6 Hydroxydopamine)IBA 04/2013
1	Haloperidol (Haldol)FDA LinkGeneric 03/2012
1	NeurotoxinsIBA 12/2011
1	MecamylamineIBA 06/2010
1	Conotoxins (Conotoxin)IBA 03/2008
1	Analgesics (Analgesic Drugs)IBA 03/2008
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 05/2007
1	Nomifensine (Nomifensin)IBA 03/2005
1	methoxyphenyl piperazinylIBA 11/2004
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2004

Therapy/Procedure

30	Therapeutics 01/2019 - 01/2002